Provided by Tiger Trade Technology Pte. Ltd.

C4 Therapeutics, Inc.

3.51
+0.11003.24%
Post-market: 3.50-0.0094-0.27%18:47 EDT
Volume:1.48M
Turnover:5.11M
Market Cap:431.82M
PE:-3.86
High:3.53
Open:3.48
Low:3.36
Close:3.40
52wk High:5.17
52wk Low:1.69
Shares:123.03M
Float Shares:94.52M
Volume Ratio:0.79
T/O Rate:1.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9085
EPS(LYR):-1.2666
ROE:-48.14%
ROA:-19.25%
PB:1.75
PE(LYR):-2.77

Loading ...

May 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 14, 2025

Major Issues Report

Form 8-K - Current report
Feb 27, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 27, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 27, 2025

Major Issues Report

Form 8-K - Current report
Jan 14, 2025

Major Issues Report

Form 8-K - Current report
Dec 09, 2024

Major Issues Report

Form 8-K - Current report
Nov 20, 2024

Major Issues Report

Form 8-K - Current report
Nov 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 08, 2024

Correspondence

Form CORRESP - Correspondence
Nov 08, 2024

Correspondence

Form CORRESP - Correspondence
Oct 31, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 31, 2024

Major Issues Report

Form 8-K - Current report
Oct 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 16, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]